A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
University of Chicago
University of Chicago
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Stanford University
University of Chicago
Ruijin Hospital
Institute of Hematology & Blood Diseases Hospital, China
Goethe University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
University Hospital Schleswig-Holstein
University Hospital Muenster
King Faisal Specialist Hospital & Research Center
M.D. Anderson Cancer Center
Universitätsklinikum Hamburg-Eppendorf
Therapeutic Advances in Childhood Leukemia Consortium
University of Michigan Rogel Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Sun Yat-sen University
Goethe University
Goethe University
Goethe University
Goethe University